Document 0095
 DOCN  M9440095
 TI    Incidence of CD4+ IL-2R alpha+ and CD4+ CD45RA+ T-cells in progressive
       multiple sclerosis and the influence of short-term (3 months) FK 506
       therapy.
 DT    9404
 AU    Thomson AW; Woo J; Lemster B; Irish W; Huang LL; Carroll PB; Rilo HR;
       Abu-Elmagd K; Eidelman B; Department of Surgery, University of
       Pittsburgh Medical Center,; Pennsylvania 15213.
 SO    Ann N Y Acad Sci. 1993 Nov 30;696:245-9. Unique Identifier : AIDSLINE
       MED/94152922
 DE    Adult  Antigens, CD45/*ANALYSIS  CD4-CD8 Ratio  Female
       FK-506/*THERAPEUTIC USE  Human  Male  Middle Age  Multiple
       Sclerosis/DRUG THERAPY/*IMMUNOLOGY  Receptors, Interleukin-2/*ANALYSIS
       T4 Lymphocytes/*DRUG EFFECTS/IMMUNOLOGY  JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).